Another Antibiotic Success Story as Tetraphase's Eravacycline Meets Goal

 
• By Kevin Grogan

Three antibiotics in just over a week have impressed in Phase III trials, with Tetraphase, The Medicines Company and Paratek all confident of being on the market in the next year

Matches
Fired up: The IGNITE4 study is pushing Tetraphase antibiotic closer to approval • Source: Shutterstock

More from Anti-infective

More from Therapy Areas